J. Domagala-Kulawik (Warsaw, Poland), M. Paesmans (Brussels, Belgium)
Global screening of AKT/PI3K signaling molecules for non-small cell lung cancer and its prognosis
D. Liu, R. Pu, W. Li, B. Chen, N. Guo (Chengdu, China)
|  |
The clinical and pathologic features according to expression of acyl protein thioesterase-1 in stage I non-small cell lung cancer
J. Shin, C. Lee, H. Kim, C. Ahn, Y. Chang (Seoul, Chuncheon, Republic Of Korea)
| |
The impact of thrombosis events in excised tumor tissues on the prognosis of non-small cell lung cancer
W. H. Chen, Y. H. Zhang, C. Wang, Y. H. Yang (Bei Jing, China)
|  |
Hypoxia inducible factor-1 alpha (HIF-1 alpha) expression was correlated with the survival in patients with small cell lung cancer (SCLC)
T. C. Y. Tsao, L. Chang-Sheng, Y. Shun-Fa, C. Ya-Wen (Taichung, Changhua, Taiwan)
| |
Association of KIR genes and their ligands with non-small cell lung cancer
E. Passowicz-Muszynska, R. Jankowska, A. Wisniewski, I. Nowak, E. Majorczyk, P. Kusnierczyk (Wroclaw, Poland)
| |
Experimental asthma does not impact chemical lung carcinogenesis in mice
K. Doris, S. P. Karabela, D. C. Simoes, S. Magkouta, C. Kairi, C. Roussos, S. Zakynthinos, I. Kalomenidis, G. T. Stathopoulos (Greece)
| |
Analysis of the prognosis value of the mitochondrial activity in resected non-small cell lung cancer (NSCLC)
R. Pozo Rivas, R. Alonso Moralejo, R. García Luján, P. Benavides Mañas, A. López Encuentra (Madrid, Spain)
| |
Prx1 provides resistance to docetaxel-induced apoptosis in lung cancer cells
H. R. Kim, E. T. Jeong, K. E. Hwang, S. H. Yang (Iksan, Republic Of Korea)
| |
Vascular endothelial growth factor C is a predictor of early recurrence and poor prognosis of resected stage I non-small cell lung cancer in Taiwan
S. C. Chen, W. E. Cheng, C. M. Shih, G. C. Tseng, C. Y. Chen (Taichung, Taiwan)
| |
Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer
K. Yasuda, M. Nakata, A. Maeda (Kurasiki, Japan)
| |
The positive prognostic impact of Bcl-xl and Bcl-2 in chemo-naive lung cancer patients depends on stage and histology
L. H. Schmidt, T. Spieker, A. Marra, A. Kümmel, A. Faldum, S. Koschmieder, C. Müller-Tidow, R. Wiewrodt (Ostercappeln, Germany)
| |
Apelin expression is a prognostic factor in non-small cell lung cancer
B. Hegedus, J. Berta, I. Kenessey, J. Tovari, F. Renyi-Vamos, H. Ankersmit, J. Timar, W. Klepetko, B. Dome (Austria; Budapest, Hungary)
| |
Different profile of hyaluronidase expression is associated with histological types and prognosis in lung cancer
V. Sá, E. Cuentas, D. Carraro, E. Olivieri, F. Soares, T. Takagaki, V. Capelozzi (São Paulo, Brazil)
| |
HER2/Neu overexpression as independent negative prognostic factor for non-small cell lung cancer
O. Sukhoversha, I. Bilen‘kiy, S. Chekan (Dnipropetrovs‘k, Ukraine)
| |
The association of p53 and p21 expression with clinicopathological parameters and prognosis in non-small cell lung cancer
N. Mendil, M. Önal, E. Özaydin, E. Çakir, S. Atikcan, M. Ögretensoy (Ankara, Turkey)
| |
The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer
O. Sukhoversha (Dnipropetrovsk, Ukraine)
| |
Increased levels of fractional exhaled nitric oxide after chemotherapy for lung cancer. Ongoing study
K. Porpodis, P. Zarogoulidis, T. Kontakiotis, E. Eleftheriadou, D. Papakosta, K. Zarogoulidis (Thessaloniki, Greece)
| |
The value of adiponectin as an inflammatory marker in lung cancer?
M. Serter, S. Kirdar, E. Ceylan, T. Kavak, B. Gültekin (Aydin, Turkey)
| |